Cargando…

The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review

Fibromyalgia (FM) is a chronic pain sensitivity syndrome characterized by diffuse musculoskeletal pain and many other systemic manifestations. Low-dose naltrexone (LDN) has been increasingly used as an off-label treatment option in FM. However, current evidence on the safety and efficacy of LDN in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Juan, Shin, Kyung-Min, Do, Alex, Bierle, Dennis M, Abu Dabrh, Abd Moain, Yin, Ziying, Bauer, Brent A, Mohabbat, Arya B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039621/ https://www.ncbi.nlm.nih.gov/pubmed/36974308 http://dx.doi.org/10.2147/JPR.S395457

Ejemplares similares

Ginseng for the Treatment of Chronic Fatigue Syndrome: A Systematic Review of Clinical Studies
por: Yang, Juan, et al.
Publicado: (2022)

Not Until We Lose Our Sanity or Anymore Lives
por: Abu Dabrh, Abd Moain
Publicado: (2019)

Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in Patients With Fibromyalgia
por: Munipalli, Bala, et al.
Publicado: (2022)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
por: Jackson, Daniel, et al.
Publicado: (2021)

Health and Wellness Coaching in Serving the Needs of Today’s Patients: A Primer for Healthcare Professionals
por: Perlman, Adam I, et al.
Publicado: (2020)

Fibromyalgia and Chronic Fatigue Syndrome in the Age of COVID-19
por: Mohabbat, Arya B., et al.
Publicado: (2020)

Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
por: Parkitny, Luke, et al.
Publicado: (2017)

Sharing is Caring: Minimizing the Disruption with Palliative Care
por: Abu Dabrh, Abd Moain, et al.
Publicado: (2018)

Prevalence, Demographics, and Risk of Severe Acute COVID-19
por: Munipalli, Bala, et al.
Publicado: (2021)

Use of Complementary and Integrative Therapies by Fibromyalgia Patients: A 14-Year Follow-up Study
por: Mohabbat, Arya B., et al.
Publicado: (2019)

Effects of Naltrexone on Pain Sensitivity and Mood in Fibromyalgia: No Evidence for Endogenous Opioid Pathophysiology
por: Younger, Jarred W., et al.
Publicado: (2009)

Depression in Fibromyalgia Patients May Require Low-Dose Naltrexone to Respond: A Case Report
por: Siembida, Jagoda, et al.
Publicado: (2022)

Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia
por: Munipalli, Bala, et al.
Publicado: (2022)

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
por: Bruun, Karin Due, et al.
Publicado: (2021)

Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
por: Munipalli, Bala, et al.
Publicado: (2022)

Utilization of Overnight Pulse Oximetry in Fibromyalgia Patients
por: Clark, Stephanie D, et al.
Publicado: (2019)

Current trends in health coaching for chronic conditions: A systematic review and meta-analysis of randomized controlled trials
por: Yang, Juan, et al.
Publicado: (2020)

Health Habits of Employees in a Large Medical Center: Time Trends and Impact of a Worksite Wellness Facility
por: Abu Dabrh, Abd Moain, et al.
Publicado: (2016)

Does the chronic care model meet the emerging needs of people living with multimorbidity? A systematic review and thematic synthesis
por: Boehmer, Kasey R., et al.
Publicado: (2018)

“No Waiting” in the “Waiting Room”: The Self-rooming Patient Pilot Study
por: Presutti, Richard J, et al.
Publicado: (2019)

Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial
por: Paula, Tânia Maria Hendges de, et al.
Publicado: (2022)

Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia
por: Partridge, Sarah, et al.
Publicado: (2023)

Health assessment of commercial drivers: a meta-narrative systematic review
por: Abu Dabrh, Abd Moain, et al.
Publicado: (2014)

Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2011)

Bridging Intention and Action for Employee Well-Being Using the Intentional Action (InAct) Process: Workshop-Lecture Series
por: Perlman, Adam I, et al.
Publicado: (2021)

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
por: Driver, C. Noelle, et al.
Publicado: (2023)

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
por: O'Kelly, Brendan, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Naltrexone Combination Therapy in Older Patients with Severe Pruritus
por: Lee, Jungsoo, et al.
Publicado: (2016)

Safety and Efficacy of Medical Cannabis in Fibromyalgia
por: Sagy, Iftach, et al.
Publicado: (2019)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

Treatment of psoriasis vulgaris using low-dose naltrexone
por: Bridgman, Alanna C., et al.
Publicado: (2018)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
por: Toljan, Karlo, et al.
Publicado: (2018)

Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19
por: Knight, Dacre R.T., et al.
Publicado: (2022)

Postacute Sequelae of SARS-CoV-2 Infection—Lessons Learned From a Coordinated Health System Response
por: Ganesh, Ravindra, et al.
Publicado: (2022)

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy
por: Zashin, Scott
Publicado: (2019)

Low-dose naltrexone as a treatment for chronic fatigue syndrome
por: Bolton, Monica Jane, et al.
Publicado: (2020)

Safety and efficacy of naltrexone for weight loss in adult patients – a systematic review
por: Kulak-Bejda, Agnieszka, et al.
Publicado: (2020)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_75r68lh4oj0qhovdt0b4i5tqt4